data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Immutep
(NASDAQ:IMMP)
$2.12
-0.04[-1.85%]
Last update: 1:08PM
Day High/Low2.1 - 2.2
52 Week High/Low1.85 - 5
Open / Close2.15 / -
Float / Outstanding- / 85.4M
Vol / Avg.61.5K / 119.6K
Mkt Cap181.1M
P/E-
50d Avg. Price2.42
Div / Yield-
Payout Ratio-
EPS0
Total Float-

Immutep (NASDAQ:IMMP), Quotes and News Summary

Immutep (NASDAQ: IMMP)

Day High/Low2.1 - 2.2
52 Week High/Low1.85 - 5
Open / Close2.15 / -
Float / Outstanding- / 85.4M
Vol / Avg.61.5K / 119.6K
Mkt Cap181.1M
P/E-
50d Avg. Price2.42
Div / Yield-
Payout Ratio-
EPS0
Total Float-
Benzinga - 5 hours ago
Benzinga - 8 hours ago
Benzinga - Jun 3, 2022, 2:19PM
Benzinga - May 4, 2022, 5:19AM
Benzinga - Mar 30, 2022, 7:52AM
Benzinga - Mar 29, 2022, 5:34PM
Benzinga - Mar 24, 2022, 8:00AM
Benzinga - Mar 18, 2022, 5:01AM
Benzinga - Mar 18, 2022, 4:56AM
Benzinga - Mar 10, 2022, 6:22AM
Benzinga - Mar 9, 2022, 4:42PM
Benzinga - Mar 9, 2022, 4:29PM
Benzinga - Feb 11, 2022, 4:48AM
Benzinga - Dec 16, 2021, 8:31AM
Benzinga - Dec 15, 2021, 4:23PM
Benzinga - Dec 8, 2021, 9:57AM
Benzinga - Dec 2, 2021, 8:06AM
Benzinga - Dec 1, 2021, 4:29PM
Benzinga - Nov 19, 2021, 8:02AM
Benzinga - Nov 18, 2021, 4:57PM
Benzinga - Nov 15, 2021, 8:13AM
Benzinga - Nov 9, 2021, 1:12PM
Sector: Health Care.Industry: Biotechnology
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its lead product is IMP321, which involves in clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trails, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia and derives most of the revenue from the sale of the products.
Read More

Earnings

see more
FY 2021Est.ActualSurprise
EPS
(EXPECTED)2022-09-23
REV
H1 2021Est.ActualSurprise
EPS-0.020
REV2.852M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Immutep Questions & Answers

Q
How do I buy Immutep (IMMP) stock?
A

You can purchase shares of Immutep (NASDAQ: IMMP) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Immutep's (IMMP) competitors?
Q
What is the target price for Immutep (IMMP) stock?
A

The latest price target for Immutep (NASDAQ: IMMP) was reported by Ladenburg Thalmann on Tuesday, August 3, 2021. The analyst firm set a price target for 8.30 expecting IMMP to rise to within 12 months (a possible 291.51% upside). 1 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Immutep (IMMP)?
A

The stock price for Immutep (NASDAQ: IMMP) is $2.12 last updated Today at July 6, 2022, 5:08 PM UTC.

Q
Does Immutep (IMMP) pay a dividend?
A

There are no upcoming dividends for Immutep.

Q
When is Immutep (NASDAQ:IMMP) reporting earnings?
A

Immutep’s FY earnings are confirmed for Friday, September 23, 2022.

Q
Is Immutep (IMMP) going to split?
A

There is no upcoming split for Immutep.

Q
What sector and industry does Immutep (IMMP) operate in?
A

Immutep is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.